v3.26.1
Condensed Consolidated Statements of Total Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2024 $ 1,968 $ 123,277 $ (28) $ (121,715) $ 1,534 $ 434
Balance, shares at Dec. 31, 2024   108,166          
Stock-based compensation 607 607 607
Foreign currency translation adjustments 2 2 2
Net loss (5,062) (4,986) (4,986) (76)
Issuance of common stock through At the Market Offering 2,754 2,754 2,754
Issuance of common stock through At the Market Offering, shares   13,980          
Balance at Mar. 31, 2025 7,299 133,668 (26) (126,701) 6,941 358
Balance, shares at Mar. 31, 2025   165,634          
Issuance of common stock and warrants through January Confidentially Marketed Public Offering, net of financing costs 3,607 3,607 3,607
Issuance of common stock and warrants through January Confidentially Marketed Public Offering, net of financing costs, shares   26,042          
Issuance of common stock and warrants for March Registered Direct Offering and Concurrent Private Placement, net of financing costs 3,423 3,423 3,423
Issuance of common stock and warrants for March Registered Direct Offering and Concurrent Private Placement, net of financing costs, shares   17,318          
Restricted stock unit shares released
Restricted stock unit shares released, shares   128          
Balance at Dec. 31, 2024 1,968 123,277 (28) (121,715) 1,534 434
Balance, shares at Dec. 31, 2024   108,166          
Net loss (10,823)            
Balance at Jun. 30, 2025 2,076 134,193 (13) (132,416) 1,764 312
Balance, shares at Jun. 30, 2025   179,843          
Balance at Mar. 31, 2025 7,299 133,668 (26) (126,701) 6,941 358
Balance, shares at Mar. 31, 2025   165,634          
Exercise of pre-funded warrants 3 3 3
Exercise of pre-funded warrants, shares   14,209          
Stock-based compensation 522 522 522
Foreign currency translation adjustments 13 13 13
Net loss (5,761) (5,715) (5,715) (46)
Balance at Jun. 30, 2025 2,076 134,193 (13) (132,416) $ 1,764 $ 312
Balance, shares at Jun. 30, 2025   179,843          
Balance at Dec. 31, 2025 3,759 145,393 (13) (141,621)    
Balance, shares at Dec. 31, 2025   451,076          
Issuance of common stock through March Confidentially Marketed Public Offering, net of financing costs 5,057 5,057    
Issuance of common stock through March Confidentially Marketed Public Offering, net of financing costs, shares   142,421          
Exercise of pre-funded warrants 5 5    
Exercise of pre-funded warrants, shares   143,188          
Stock-based compensation 231 231    
Foreign currency translation adjustments (9) (9)    
Net loss (4,108) (4,108)    
Balance at Mar. 31, 2026 4,935 150,686 (22) (145,729)    
Balance, shares at Mar. 31, 2026   736,685          
Balance at Dec. 31, 2025 3,759 145,393 (13) (141,621)    
Balance, shares at Dec. 31, 2025   451,076          
Net loss (8,268)            
Balance at Jun. 30, 2026 3,133 153,048 (26) (149,889)    
Balance, shares at Jun. 30, 2026   2,082,648          
Balance at Mar. 31, 2026 4,935 150,686 (22) (145,729)    
Balance, shares at Mar. 31, 2026   736,685          
Exercise of pre-funded warrants 5 5    
Exercise of pre-funded warrants, shares   470,307          
Stock-based compensation 157 157    
Foreign currency translation adjustments (4) (4)    
Net loss (4,160) (4,160)    
Issuance of common stock through At the Market Offering 2,200 2,200    
Issuance of common stock through At the Market Offering, shares   875,656          
Balance at Jun. 30, 2026 $ 3,133 $ 153,048 $ (26) $ (149,889)    
Balance, shares at Jun. 30, 2026   2,082,648